| Nov 18 |
Schrödinger Broadens and Accelerates Predictive Toxicology Initiative
|
| Nov 14 |
Schrödinger Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
| Nov 13 |
Schrodinger announces expanded license agreement with Novartis
|
| Nov 13 |
Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...
|
| Nov 13 |
Q3 2024 Schrodinger Inc Earnings Call
|
| Nov 12 |
Schrödinger gains on Novartis deal despite Q3 miss
|
| Nov 12 |
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
|
| Nov 12 |
Schrödinger (SDGR) Q3 2024 Earnings Call Transcript
|
| Nov 12 |
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates
|
| Nov 12 |
Schrödinger misses top-line and bottom-line estimates; updates FY24 outlook
|
